Mc Ginn Investment Management, Inc. Bausch Health Companies Inc. Transaction History

Mc Ginn Investment Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	BUY	$7.06 - $23.63 $554,506 - $1.86 Million	78,542 Added 40.06%	274,603 $2.3 Million
Q1 2022 May 05, 2022	BUY	$21.6 - $27.79 $723,600 - $930,965	33,500 Added 20.61%	196,061 $4.48 Million
Q4 2021 Feb 07, 2022	SELL	$23.0 - $29.01 $10,051 - $12,677	-437 Reduced 0.27%	162,561 $4.49 Million
Q3 2021 Nov 02, 2021	BUY	$25.04 - $30.06 $8,138 - $9,769	325 Added 0.2%	162,998 $4.54 Million
Q2 2021 Aug 12, 2021	BUY	$27.43 - $32.7 $4.46 Million - $5.32 Million	162,673 New	162,673 $4.77 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Mc Ginn Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Mc Ginn Investment Management, Inc. with notifications on news.